What one share of Pharma-Bio Serv holds
We are a regulatory affairs, quality, compliance and technology transfer services consulting firm with headquarters in Puerto Rico, servicing the Puerto Rico, United States and European markets, and to a lesser extent the Brazilian market.
Pharma-Bio Serv’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $0.41 |
|---|---|
| Profit | $0.01 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.02 |
| Dividends | $0.07 |
| Cash and investments | $0.07 |
| Book value | $0.46 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | — | $0.02 | $0.00 | $0.02 | — | $0.24 |
| 2011 | — | $0.14 | $0.01 | $0.09 | — | $0.40 |
| 2012 | — | $0.20 | $0.01 | $0.10 | — | $0.62 |
| 2013 | — | $0.21 | $0.01 | $0.23 | — | $0.80 |
| 2014 | — | $0.10 | $0.01 | $0.13 | — | $0.89 |
| 2015 | — | $0.07 | $0.01 | $0.00 | — | $0.95 |
| 2016 | — | −$0.01 | $0.08 | −$0.05 | — | $0.95 |
| 2017 | $0.58 | −$0.06 | $0.00 | −$0.04 | — | $0.90 |
| 2018 | $0.77 | $0.06 | $0.01 | $0.16 | — | $0.88 |
| 2019 | $0.84 | $0.09 | $0.00 | −$0.10 | $0.07 | $0.90 |
| 2020 | $0.94 | $0.09 | $0.00 | $0.06 | — | $0.99 |
| 2021 | $0.87 | −$0.09 | $0.00 | $0.03 | — | $0.82 |
| 2022 | $0.84 | $0.04 | $0.00 | $0.02 | — | $0.72 |
| 2023 | $0.74 | $0.06 | $0.00 | $0.08 | — | $0.70 |
| 2024 | $0.41 | −$0.03 | $0.01 | −$0.03 | — | $0.60 |
| 2025 | $0.39 | −$0.00 | $0.00 | −$0.01 | — | $0.52 |
Common questions about Pharma-Bio Serv
How much does one share of Pharma-Bio Serv earn?
Over the last 12 months, each share of Pharma-Bio Serv earned $0.01 of profit on $0.41 of sales, keeping about 3¢ of every $1 (profit margin).
Does Pharma-Bio Serv pay a dividend?
Yes. Pharma-Bio Serv paid $0.07 per share in dividends over the last 12 months. That’s about 681¢ of each $1 of profit (payout ratio).
What is Pharma-Bio Serv’s book value per share?
Pharma-Bio Serv’s book value is $0.46 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of July 31, 2026.
How much cash and debt does each share of Pharma-Bio Serv have?
Each share of Pharma-Bio Serv has $0.07 of cash and investments, as of July 31, 2026.
What is Pharma-Bio Serv’s free cash flow per share?
−$0.02 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.